CTOs on the Move

EIS Analytics

www.eisanalytics.com

 
EIS Analytics is a Vancouver, WA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Best Fitness

Best Fitness is a Chelmsford, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

WellBiz Brands

Wellbiz Brands, Inc. is the nation`s premiere franchisor of wellness, fitness and beauty brands. With more than 600 locations, WellBiz Brands is uniquely qualified to serve the growing needs of the health and beauty conscious consumer through recurring revenue experience-based brands including Elements Massage®, Amazing Lash Studio® and Fitness Together®. Backed by a management team with nearly a century of combined leadership experience, WellBiz Brands accelerates scalable and predictable revenue growth by providing a robust platform of shared services, infrastructure and support. The company claimed three spots on the 2018 Inc. 5000 Fastest Growing Companies list and is headquartered in Englewood, Colorado.

Thirty Madison

Thirty Madison exists to deliver on healthcare`s biggest opportunities: access and affordability; patient outcomes; and patient experience. With empathy at the heart of its innovation, its proprietary care model empowers hundreds of thousands of people with ongoing conditions with accessible, effective treatments across a lifetime of care.

US HealthConnect

US HealthConnect is a Fort Washington, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Plasmatech Biopharmaceuticals

Abeona Therapeutics is focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. Abeona’s lead program is an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome (MPS IIIA and IIIB) in collaboration with patient advocate groups, researchers and clinicians. Clinical trials for Sanfilippo types A and B are anticipated to begin in 2015.